Eurofins Scientific SE

Eurofins Scientific SE is a global group of life sciences companies headquartered in Luxembourg, providing a comprehensive range of bio-analytical testing services. The company's core mission is "to contribute to a safer and healthier world by providing our customers with innovative and high-quality laboratory, research and advisory services whilst creating opportunities for our employees and generating sustainable shareholder value."

Eurofins offers an extensive portfolio of over 200,000 analytical methods across more than 950 laboratories in 59 to 62 countries. Its key services span various industries, including food and feed testing, environmental testing, pharmaceutical and cosmetic product testing, discovery pharmacology, forensics, advanced material sciences, agroscience contract research, genomics, and clinical diagnostic testing. The company primarily serves regulated B2B clients, with pharmaceuticals and food and beverage sectors representing its largest revenue pillars.

Gilles G. Martin serves as the Chairman of the Board and Chief Executive Officer. Eurofins maintains a strong market position as a global leader in bio-analytical testing and has been a component of the CAC 40 index since September 2021. Recent activities include a 6.9% revenue growth in Q1 2025, continued expansion in PFAS testing, and the acquisition of Infinity Laboratories, Inc. in September 2024 to bolster its biopharmaceutical and medical device network in the USA. In a notable development, UL Solutions Inc. entered an agreement to acquire Eurofins' Electrical and Electronics (E&E) business for approximately €580 million.